A

Active Biotech AB publ
F:BTPC

Watchlist Manager
Active Biotech AB publ
F:BTPC
Watchlist
Price: 0.0017 EUR Market Closed
Market Cap: 643.3k EUR

Wall Street
Price Targets

BTPC Price Targets Summary
Active Biotech AB publ

Wall Street analysts forecast BTPC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BTPC is 0.0305 EUR with a low forecast of 0.0279 EUR and a high forecast of 0.0338 EUR.

Lowest
Price Target
0.0279 EUR
1 540% Upside
Average
Price Target
0.0305 EUR
1 694% Upside
Highest
Price Target
0.0338 EUR
1 889% Upside
Active Biotech AB publ Competitors:
Price Targets
IMMU
Mendus AB (publ)
219% Upside
PYXS
Pyxis Oncology Inc
468% Upside
SLS
Sellas Life Sciences Group Inc
164% Upside
086900
Medy Tox Inc
10% Upside
CMPX
Compass Therapeutics Inc.
144% Upside
PRQR
ProQR Therapeutics NV
356% Upside
FHTX
Foghorn Therapeutics Inc.
97% Upside
MOLN
Molecular Partners AG
170% Upside

Revenue
Forecast

Revenue Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BTPC's stock price target?
Price Target
0.0305 EUR

According to Wall Street analysts, the average 1-year price target for BTPC is 0.0305 EUR with a low forecast of 0.0279 EUR and a high forecast of 0.0338 EUR.

Back to Top